The Patent Finder
EU

Emory University

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

471 patents currently held

91 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
47
Ending by 2030
Jan 2027
Next term end
347
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Cardiac Valve Leaflet Enhancer Devices and Systems US 11,571,305
Cited by 35 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2038.
Ends Jul 2038 · High confidence
Also notable
Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle US 10,905,586
Cited by 18 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Ends May 2027 · Medium confidence
Also notable
Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions US 8,822,462
Cited by 45 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Sep 2030 · High confidence

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 314 later US patents, top 1% of utility patents granted in 2013 in our data. Protection runs to 2029.
Ends Sep 2029 · High confidence
Also notable
Cited by 258 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Ends Feb 2029 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 7 fees due Dec 6 to 23, 2026 · next Dec 6
  • 6 fees due Jan 2 to 28, 2027 · next Jan 2
  • 16 fees due Feb 1 to 28, 2027 · next Feb 1
  • 6 fees due Mar 5 to 24, 2027 · next Mar 5
  • 8 fees due Apr 3 to 30, 2027 · next Apr 3
  • 8 fees due May 5 to 28, 2027 · next May 5
  • 9 fees due Jun 8 to 26, 2027 · next Jun 8
  • 16 fees due Jul 2 to 30, 2027 · next Jul 2
  • 5 fees due Aug 11 to 27, 2027 · next Aug 11
  • 3 fees due Sep 24 to 29, 2027 · next Sep 24
  • 11 fees due Oct 14 to 30, 2027 · next Oct 14
  • 5 fees due Nov 7 to 19, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

  • Nov 17Assignment recorded on 1 record: Painter, George R. and 3 others to Emory University Recorded Nov 17, 2026, executed Aug 7, 2015. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76789, frame 530.
  • Oct 29Assignment recorded on 2 records: Suresh, Kirthana Sreerangathama to Emory University Recorded Oct 29, 2026, executed Jun 6, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76563, frame 634.
  • 18 of the patents on this record were granted since Aug 22, 2026
  • 8 terms have ended since Aug 22, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,045,727Virus-like particles, methods of preparation, and immunogenic compositions
In force
 · High confidence
In forceHigh confidence
US 7,652,033HIF-1 Inhibitors
In force
 · High confidence
In forceHigh confidence
US 7,686,781Catheter for Modified Perfusion
In force
 · High confidence
In forceHigh confidence
US 10,905,586Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
In force
 · Medium confidence
In forceMedium confidence
US D685,387Graphical User Interface for a Display Screen or a Portion Thereof
In force
 · High confidence
In forceHigh confidence
US 7,550,299Method for Predicting Onset/Risk of Atrial Fibrillation (AF)
In force
 · High confidence
In forceHigh confidence
US 10,787,641Therapeutic Use of CD31 Expressing Cells
In force
 · High confidence
In forceHigh confidence
US 7,824,672Method for Coating Living Cells
In force
 · High confidence
In forceHigh confidence
US 7,691,289Compositions, Materials Incorporating the Compositions, and Methods of Using the Compositions and Materials
In force
 · High confidence
In forceHigh confidence
US D696,094Accessory Clamp
In force
 · High confidence
In forceHigh confidence
10 of 471 patents shown.
Pro members see all 471.
Pro members: see all 471 patents
Also on record, not counted in the 471: 91 patents in force now held by others · 176 patents ended · 282 applications pending · 434 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited